Moderna Ownership | Who Owns Moderna?
Moderna Ownership Summary
Moderna is owned by 66.45% institutional investors, 9.60% insiders, and 23.95% retail investors. Vanguard group is the largest institutional shareholder, holding 10.47% of MRNA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.85% of its assets in Moderna shares.
MRNA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Moderna | 66.45% | 9.60% | 23.95% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 40.32M | 10.47% | $1.68B |
| Baillie gifford | 38.89M | 10.10% | $1.62B |
| Blackrock funding, inc. /de | 25.79M | 6.70% | $1.07B |
| Fmr | 18.66M | 4.85% | $776.08M |
| Theleme partners llp | 7.31M | 1.90% | $303.82M |
| Geode capital management | 7.24M | 1.88% | $300.22M |
| Ubs group | 5.07M | 1.32% | $210.95M |
| Invesco | 5.01M | 1.30% | $208.17M |
| Flagship pioneering | 4.63M | 1.20% | $192.60M |
| Norges bank | 3.94M | 1.02% | $163.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Flagship pioneering | 4.63M | 57.63% | $192.60M |
| Merck | 2.31M | 37.19% | $95.97M |
| Theleme partners llp | 7.31M | 20.36% | $303.82M |
| Sassicaia capital advisers | 14.50K | 14.58% | $602.91K |
| Washington university | 150.00K | 5.31% | $6.24M |
| Cutter capital management, lp | 197.50K | 3.37% | $8.21M |
| Intrinsic value partners | 36.26K | 1.51% | $1.51M |
| Bellevue group | 1.60M | 1.28% | $66.56M |
| Baillie gifford | 38.89M | 1.24% | $1.62B |
| Quattro financial advisors | 84.60K | 0.89% | $3.44M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 3.94M | 0.02% | 3.94M |
| Jane street group | 3.62M | 0.03% | 2.98M |
| Ubs group | 5.07M | 0.04% | 2.80M |
| Merck | 2.31M | 37.19% | 2.31M |
| Voloridge investment management | 2.59M | 0.38% | 2.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baillie gifford | 38.89M | 1.24% | -3.57M |
| Mawer investment management | - | - | -1.90M |
| Jpmorgan chase | 523.18K | 0.00% | -1.70M |
| Wellington management group llp | 3.92M | 0.03% | -1.31M |
| Ark investment management | - | - | -1.16M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 3.94M | 0.02% | 3.94M | $163.83M |
| Merck | 2.31M | 37.19% | 2.31M | $95.97M |
| Grantham, mayo, van otterloo | 547.81K | 0.07% | 547.81K | $22.78M |
| Hudson bay capital management lp | 500.02K | 0.07% | 500.02K | $20.79M |
| Susquehanna fundamental investments | 385.68K | 0.23% | 385.68K | $16.04M |
Sold Out
| Holder | Change |
|---|---|
| Mendota financial group | -1.00 |
| Thompson investment management | -2.00 |
| Whittier trust co of nevada | -5.00 |
| Voisard asset management group | -5.00 |
| Clear point advisors | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 727 | -15.17% | 255,844,003 | -0.71% | 66 | 1.48% | 324 | 0.31% | 242 | -24.38% |
| Sep 30, 2024 | 853 | -17.02% | 257,576,845 | -1.79% | 66 | 1.42% | 321 | -31.41% | 319 | 5.28% |
| Jun 30, 2024 | 1,028 | 6.09% | 262,270,346 | 1.07% | 68 | 1.49% | 468 | 6.61% | 303 | 1.68% |
| Mar 31, 2024 | 969 | 1.89% | 259,490,653 | 0.92% | 67 | 1.50% | 439 | 6.30% | 298 | -11.31% |
| Dec 31, 2023 | 951 | -0.94% | 257,131,574 | 4.31% | 67 | 1.61% | 413 | -5.49% | 336 | 10.16% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 10.99M | 2.85% | 80.25K |
| Vanguard Total Stock Mkt Idx Inv | 10.91M | 2.83% | 16.27K |
| Vanguard Institutional 500 Index Trust | 9.39M | 2.43% | 57.48K |
| Scottish Mortgage Ord | 8.63M | 2.24% | - |
| Invesco QQQ Trust | 7.63M | 1.98% | - |
| Vanguard Mid Cap Index Institutional | 7.48M | 1.94% | 33.83K |
| Fidelity Growth Compy Commingled Pl S | 6.75M | 1.75% | 59.79K |
| Vanguard International Growth Inv | 6.40M | 1.66% | -2.16M |
| Fidelity Growth Company Fund | 4.78M | 1.24% | 40.30K |
| Fidelity 500 Index | 4.24M | 1.10% | 18.89K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 03, 2025 | Bancel Stephane | Chief Executive Officer | Buy | $1.81M |
| Mar 03, 2025 | Bancel Stephane | Chief Executive Officer | Buy | $3.19M |
| Mar 03, 2025 | SAGAN PAUL | - | Buy | $1.00M |
| Dec 09, 2024 | Klinger Shannon Thyme | Chief Legal Officer | Sell | $23.64K |
| Dec 03, 2024 | Klinger Shannon Thyme | Chief Legal Officer | Sell | $4.85K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 3 | - |
| 2024 Q4 | - | 8 |
| 2024 Q3 | - | 29 |
| 2024 Q2 | - | 108 |
| 2024 Q1 | - | 29 |
MRNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools